3Dバイオプリントの世界市場予測:コンポーネント別、材料別、用途別、エンドユーザー別

LINEで送る

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 22)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary (Page No. – 32)
4 Premium Insights (Page No. – 36)
4.1 3D Bioprinting Market Overview
4.2 Market Share, By Component and Region
4.3 Market, By Material, 2019 vs 2024 (USD Million)
4.4 Market, By End User, 2019 vs 2024 (USD Million)
4.5 Geographic Snapshot of the Market
5 Market Overview (Page No. – 41)
5.1 Introduction
5.2 3D Bioprinting Approaches
5.2.1 Biomimicry
5.2.2 Autonomous Self-Assembly
5.2.3 Mini-Tissue Building Blocks
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
5.3.1.2 Rising Public and Private Funding to Support Bioprinting Research Activities
5.3.1.3 Technological Advancements in the 3D Bioprinting Industry
5.3.2 Restraints
5.3.2.1 Dearth of Skilled Professionals
5.3.2.2 High Development & Production Costs
5.3.2.3 Lack of Regulatory Guidelines Governing 3D Bioprinting
5.3.3 Opportunities
5.3.3.1 Rising Demand for Organ Transplants
5.3.3.2 Growing Awareness of 3D Bioprinting
5.3.3.3 Growing Demand for Regenerative Medicine & Stem Cell Research
5.3.4 Challenges
5.3.4.1 Socioethical Concerns Related to the Use of 3D Bioprinted Products
5.3.4.2 High Cost of 3D Bioprinting
5.3.4.3 Process Control & Understanding
6 3D Bioprinting Market, By Component (Page No. – 49)
6.1 Introduction
6.2 3D Bioprinters
6.2.1 3D Bioprinters Market, By Technology
6.2.1.1 Microextrusion Bioprinting
6.2.1.1.1 Increasing Research in the Field of Microextrusion is Fueling the Adoption of This Technology
6.2.1.2 Inkjet 3D Bioprinting
6.2.1.2.1 High Cell Viability and Low Cost have Resulted in the Increased Demand for Inkjet 3D Bioprinting
6.2.1.3 Laser-Assisted Bioprinting
6.2.1.3.1 Laser-Assisted Bioprinting is One of the Highest-Resolution Bioprinting Technologies Available in the 3D Bioprinting Industry
6.2.1.4 Magnetic 3D Bioprinting
6.2.1.4.1 Accuracy and Speed in the Formation and Processing of Cultured Tissues are the Major Advantages Associated With Magnetic 3D Bioprinting
6.2.1.5 Other Technologies
6.3 Bioinks
6.3.1 Natural Bioinks
6.3.1.1 Natural Bioinks are the Most Commonly Preferred Bioinks in the 3D Bioprinting Process
6.3.2 Hybrid Bioinks
6.3.2.1 Hybrid Bioinks Possess High Mechanical Strength and Great Biocompatibility
6.3.3 Synthetic Bioinks
6.3.3.1 Improved Mechanical Strength and Consistency Offered By Synthetic Bioinks to Drive Market Growth
7 3D Bioprinting Market, By Material (Page No. – 61)
7.1 Introduction
7.2 Living Cells
7.2.1 Ethical Issues Associated With the Use of Living Cells in Organ Development to Hamper Market Growth
7.3 Hydrogels
7.3.1 Dynamic Properties of Hydrogels are Supporting Their Increased Use in 3D Tissue Engineering and Biomedical Applications
7.4 Extracellular Matrices
7.4.1 Ecm has Emerged as A Promising Tool in Tissue Engineering
7.5 Other Biomaterials
8 3D Bioprinting Market, By Application (Page No. – 67)
8.1 Introduction
8.2 Research Applications
8.2.1 Drug Research
8.2.1.1 Drug Research Segment to Register the Highest Growth During the Forecast Period
8.2.2 Regenerative Medicine
8.2.2.1 Growing Demand for Organ Transplants to Support Market Growth
8.2.3 3D Cell Culture
8.2.3.1 Rising Focus on Developing Alternatives to Animal Testing to Support Market Growth
8.3 Clinical Applications
8.3.1 Skin
8.3.1.1 Growing Number of Aesthetic and Reconstruction Surgeries to Propel Market Growth
8.3.2 Bone & Cartilage
8.3.2.1 Increasing Incidence of Musculoskeletal Conditions to Drive the Demand for Bone Grafts
8.3.3 Blood Vessels
8.3.3.1 Increasing Research Activities Focused on the 3D Bioprinting of Blood Vessels is the Major Factor Driving Market Growth
8.3.4 Other Clinical Applications
9 3D Bioprinting Market, By End User (Page No. – 78)
9.1 Introduction
9.2 Research Organizations & Academic Institutes
9.2.1 Research Organizations & Academic Institutes are the Fastest-Growing End Users of 3D Bioprinting
9.3 Biopharmaceutical Companies
9.3.1 Increasing Prevalence of Chronic Diseases to Drive the Adoption of 3D Bioprinting Among Biopharmaceutical Companies
9.4 Hospitals
9.4.1 3D Printing Offers A Customized Surgical Planning Tool for Hospitals
10 3D Bioprinting Market, By Region (Page No. – 83)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 The US Dominates the Global Market
10.2.2 Canada
10.2.2.1 Government Initiatives to Support the Growth of the Market in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Demand for Organ Transplants to Drive Market Growth
10.3.2 UK
10.3.2.1 Increase in Funding and Grants to Support Research Activities Related to 3D Bioprinting in the UK
10.3.3 France
10.3.3.1 Growing Cosmetics Industry in France to Propel the Adoption of 3D Bioprinting Technologies
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Strong Research Base and Government Support to Drive the Growth of the Market in Japan
10.4.2 China
10.4.2.1 The Market in China is Projected to Register Significant Growth Owing to Rising Regenerative Medicine Research
10.4.3 India
10.4.3.1 Initiatives to Raise Awareness and Develop Novel Products to Support Market Growth in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.1.1 Growing Medical Tourism to Contribute to the Growth of the Market in the Region
10.5.2 Middle East & Africa
10.5.2.1 Lack of Awareness and Underdeveloped Infrastructure to Hamper Market Growth
11 Competitive Landscape (Page No. – 142)
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Scenario
11.4 Competitive Leadership Mapping
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive
11.6.1 Visionary Leaders
11.6.2 Innovators
11.6.3 Dynamic Differentiators
11.6.4 Emerging Companies
12 Company Profiles (Page No. – 149)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Advanced Solutions Life Sciences
12.2 Allevi Inc.
12.3 Aspect Biosystems Ltd.
12.4 Cellink
12.5 Cyfuse Biomedical K.K.
12.6 Digilab, Inc.
12.7 Envisiontec
12.8 Gesim
12.9 Nano3D Biosciences, Inc.
12.10 Organovo Holdings, Inc.
12.11 Poietis
12.12 Regenhu
12.13 Regenovo Biotechnology Co., Ltd.
12.14 Rokit Healthcare
12.15 Tevido Biodevices
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 174)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様